Yale study identifies a new class of drug targets for aggressive leukemia
A new Yale-led study sheds light on an unexplored class of new cancer drugs that are being designed to hyperactivate leukemia cell signaling, thus killing the cancer.
More from Connecticut Colleges
Yale University
Arikha Moses '98 Ph.D. named Chair of Yale Day of Service 2027
Connecticut Colleges
•
13h ago
Yale University
Considering 'core decompression' surgery to save ailing hip joints
Connecticut Colleges
•
13h ago
Yale University
When a policy hits its target, where does the value go?
Connecticut Colleges
•
14h ago
University of Connecticut
The Center for Addiction Science and Innovation Holds First Outreach Event
Connecticut Colleges
•
16h ago
University of Connecticut
'Healthy Rounds': Supercharging the Immune System
Connecticut Colleges
•
17h ago